Breaking News

Financial Report: PAREXEL 1Q11

Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%).

Related CONTENT

11.02.10

PAREXEL 1Q11

1Q Revenues: $342.3 million (+11%)

1Q Earnings: $17.8 million (+44%)

Comments: Clinical Research Services (CRS) revenue was $231.6 million in the quarter (+14%). PAREXEL Consulting & Medical Communications Services (PCMS) accounted for $28.3 million (-2%). Perceptive Informatics, Inc. (PII) Service revenue was $35.8 million (+25%). The Americas accounted for $132.9 million (+31%), Europe, Middle East & Africa, $125.5 million (-3%), and Asia/Pacific, $37.4 million (+31%).

Suggested For You

Clinical Trials are Transforming Right Before Our Eyes

Clinical Trials are Transforming Right Before Our Eyes

Clinical Ink Adds Executives

Clinical Ink Adds Executives

Thermo Fisher Scientific to Acquire PPD

Thermo Fisher Scientific to Acquire PPD

Thermo Fisher Acquires PPD for $17.4B

Thermo Fisher Acquires PPD for $17.4B

Intravacc Completes Project for Provention Bio’s Vax Candidate

Intravacc Completes Project for Provention Bio’s Vax Candidate

Parexel Appoints Chief Patient Officer

Parexel Appoints Chief Patient Officer

SGS Initiates U.S. COVID-19 Clinical Trials

SGS Initiates U.S. COVID-19 Clinical Trials

CROS NT Expands Medidata Pact

CROS NT Expands Medidata Pact

KCR Expands U.S. Presence

KCR Expands U.S. Presence

CROs & Next-Gen Drug Development

CROs & Next-Gen Drug Development

How to Maximize Potential and Sidestep Pitfalls of MAPs

How to Maximize Potential and Sidestep Pitfalls of MAPs

INC Research Makes Executive Appointments

INC Research Makes Executive Appointments

PAREXEL Appoints SVP, CFO

PAREXEL Appoints SVP, CFO

Financial Report: PAREXEL

Financial Report: PAREXEL

Related Breaking News

Breaking News | Industry News | Promotions & Moves

Benuvia Manufacturing Appoints K. Scott Aladeen as Chief Operating Officer

Aladeen has four decades of pharmaceutical experience.
10.27.21
Bio News | Breaking News | Facilities | Industry News

Bionova Scientific Opens Biologics Manufacturing Facility

Unveils commercial-ready GMP biologics manufacturing facility at grand opening event attended by clients, vendors, industry leaders and government officials.
10.27.21
Breaking News | Industry News | Promotions & Moves

Exothera Appoints Hanna Lesch as Chief Technology Officer

Lesch has dedicated her career to gene therapy and has held several director positions.
10.27.21
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News

Fujifilm Diosynth Biotechnologies, Istari Oncology Enter Manufacturing Agreement

To advance its viral immunotherapy PVSRIPO.
10.27.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Jaguar Gene Therapy Announces Plans for New Commercial Manufacturing Facility in NC

The 174,000-square-foot facility will support future clinical and commercial production of the company’s initial programs.
10.27.21
Breaking News | Industry News

CPhI Annual Report Predicts the Pharma Environment in 2030

Releases new findings ahead of CPhI Worldwide, which is being held for the first time in two years at the Fiera Milan, Italy.
10.27.21
APIs | Breaking News | Collaborations & Alliances | Industry News

Phlow Included in BARDA CDMO Network

Will provide domestic API capability for essential medicines and medical countermeasures.
10.27.21
Breaking News | Collaborations & Alliances | Industry News

Recro Becomes Commercial Supplier for Otsuka

The CDMO enters master commercial supply and services agreement with the Japanese pharma major.
10.27.21
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Process Development

Waters and Sartorius Enter Bioprocessing Partnership

Collaboration to help bioprocess scientists accelerate clone selection and process development.
10.27.21
Breaking News | Industry News | Promotions & Moves

Abzena Promotes Dr. Louise Duffy as Chief Technical Officer

Duffy has more than 30 years’ experience in the industry.
10.27.21
Breaking News | Collaborations & Alliances

Rentschler Biopharma, XL-Protein Enter Manufacturing Pact

Will manufacture a long-acting, hyperactive recombinant human deoxyribonuclease I.
10.26.21
Collaborations & Alliances | Drug Development

Secarna, Denali Therapeutics Expand Strategic CNS Pact

To broaden use of Secarna's ASO discovery and development platform LNAplus and Denali's blood-brain barrier Transport Vehicle technology.
10.26.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

BioNTech to Build mRNA Vaccine Mfg. Facility in Africa

The first mRNA manufacturing facility in Africa will enable an annual manufacturing capacity of several hundreds of million mRNA vaccine doses.
10.26.21
Collaborations & Alliances | Drug Delivery

Aptar Pharma Enters Exclusive Partnership with Stallergenes Greer

Will develop a novel digital health ecosystem for allergen immunotherapy treatment.
10.26.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Invests $230M in Harmans Gene Therapy Campus

Will house 18 CGMP viral vector manufacturing suites designed to accommodate multiple bioreactors up to 2,000-liter scale and commercial manufacturing.
10.26.21